DisclosureWe earn commission on partner links; ranking is set by our published methodology — not advertisers.
For compounded semaglutide, the pharmacy behind your dose matters — but most platforms don't name it. We rate the telehealth providers that sell compounded GLP-1 on three public-disclosure signals. This is about transparency, not a safety verdict.
Pharmacy: MedisourceRx (503B outsourcing facility; Hims-affiliated since 2024)
Names its 503B outsourcing facility and is LegitScript-certified — the most disclosure of the three. Clearly states compounded product is not FDA-approved.
⚠ An FDA warning letter (2025–26) cited a facility linked to the compounding supply chain — verify current FDA inspection status before ordering.
Verified 2026-06 · source
States it ships from state-licensed pharmacy partners and runs quality checks, but does not publicly name the specific pharmacy or its 503A/503B classification.
Verified 2026-06 · source
Makes 503A/503B claims but does not name the fulfilling pharmacy publicly, and does not publish Certificate-of-Analysis or per-lot testing on its consumer pages.
Verified 2026-06 · source
Three public-disclosure signals, each worth up to one point: (1) does the provider name the pharmacy that compounds your dose, (2) does it cite accreditation (LegitScript, a state-board license, or FDA 503B registration), and (3) does it disclose testing (Certificate of Analysis, potency and sterility). High = 2.5–3, Partial = 1.5–2, Low = under 1.5.
Important:“Not public” means we couldn’t find it disclosed on the provider’s consumer pages — it does notmean the medication is unsafe, and the information may be available on request. Branded providers that dispense FDA-approved Wegovy or Zepbound through licensed pharmacies are out of scope here — the compounding-disclosure question doesn’t apply to them. Provider published something we missed? Send us the public source and we’ll update the row.
New to this? Start with how to evaluate compounded GLP-1 quality and what 503(a) vs 503(b) means. If a provider won’t name its pharmacy, see red flags to avoid.
LoseLab is independent and earns affiliate commission on some outbound clicks, but this scorecard is set by public disclosure only — disclosure scores are never influenced by commercial relationships. Compounded medications are not FDA-approved.